top of page
Search
All Posts
Promising Outcomes from Locus Biosciences' Phase 2 ELIMINATE Trial using Bacteriophage Therapy for Urinary Tract Infections
Locus Biosciences is advancing the ELIMINATE clinical trial, a pivotal study evaluating LBP-EC01, a CRISPR-enhanced bacteriophage therapy...
Lindsey VanDyke
Apr 302 min read
Unlocking the Power of Phage Therapy for Antibiotic Resistance
Antibiotic resistance continues to be a growing concern in the medical field, leading to a pressing need for alternative treatments. One...
Lindsey VanDyke
Apr 152 min read
Join the Fight Against Antibiotic Resistance with Phage Solutions
In the face of a growing global health concern, the fight against antibiotic resistance has never been more pressing. With traditional...
Lindsey VanDyke
Apr 151 min read
bottom of page